Nuformix plc Innovative Drug Repurposing with Breakthroughs in Fibrosis and Oncology
Nuformix plc (LON:NFX), a pharmaceutical development company targeting unmet medical needs in fibrosis and oncology via drug repurposing, has announced its audited results for the eighteen months ended 30 September 2023 following the